Showing results (171-180 of 331) with videos related to
Sort By:
Pageof 34
Scandinavian Journal of Gastroenterology|November 4, 2005
Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneumFernando Magro, Pedro Pereira, Fatima Carneiro, et al.Journal of Crohn'S & Colitis|April 21, 2016
DNA Damage and Oxidative DNA Damage in Inflammatory Bowel DiseaseCristiana Pereira, Rosa Coelho, Daniela Grácio, et al.Journal of Crohn'S & Colitis|March 6, 2025
Higher dietary glycemic index, but not glycemic load, is associated with increased risk of ulcerative colitis: a prospective cohort studyShuyu Ye, Tian Fu, Yiwen Tu, et al.Immunobiology|January 29, 2011
Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infectionNair Campos, Fernando Magro, Ana Rita Castro, et al.Clinical and Translational Gastroenterology|March 11, 2021
Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel DiseasePedro Pinto-Lopes, Francisco Melo, Joana Afonso, et al.Inflammatory Bowel Diseases|November 20, 2023
Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn's Disease: A Propensity Score-Matched AnalysisSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.Nature Reviews. Gastroenterology & Hepatology|May 19, 2026
Precision nutrition for the prevention and management of inflammatory bowel diseaseJie Chen, Lintao Dan, Judith Wellens, et al.Clinical and Translational Gastroenterology|March 29, 2022
Incidence Trends of Inflammatory Bowel Disease in a Southern European Country: A Mirror of the Western World?Mafalda Santiago, Francisco Stocker, Paula Ministro, et al.Inflammatory Bowel Diseases|August 10, 2024
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference StudyJavier P Gisbert, Stefan Schreiber, Corey A Siegel, et al.United European Gastroenterology Journal|December 14, 2023
Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's diseaseSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.Pageof 34